LU, SIMONE
LU, SIMONE
Cd4 t cell–dependent rejection of beta-2 microglobulin null mismatch repair–deficient tumors
2021-01-01 Germano G.; Lu S.; Rospo G.; Lamba S.; Rousseau B.; Fanelli S.; Stenech D.; Le D.T.; Hays J.; Totaro M.G.; Amodio V.; Chila R.; Mondino A.; Diaz L.A.; Di Nicolantonio F.; Bardelli A.
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study
2023-01-01 Bai, Xue; Shaheen, Ahmed; Grieco, Charlotte; d'Arienzo, Paolo D; Mina, Florentia; Czapla, Juliane A; Lawless, Aleigha R; Bongiovanni, Eleonora; Santaniello, Umberto; Zappi, Helena; Dulak, Dominika; Williamson, Andrew; Lee, Rebecca; Gupta, Avinash; Li, Caili; Si, Lu; Ubaldi, Martina; Yamazaki, Naoya; Ogata, Dai; Johnson, Rebecca; Park, Benjamin C; Jung, Seungyeon; Madonna, Gabriele; Hochherz, Juliane; Umeda, Yoshiyasu; Nakamura, Yasuhiro; Gebhardt, Christoffer; Festino, Lucia; Capone, Mariaelena; Ascierto, Paolo Antonio; Johnson, Douglas B; Lo, Serigne N; Long, Georgina V; Menzies, Alexander M; Namikawa, Kenjiro; Mandala, Mario; Guo, Jun; Lorigan, Paul; Najjar, Yana G; Haydon, Andrew; Quaglino, Pietro; Boland, Genevieve M; Sullivan, Ryan J; Furness, Andrew J S; Plummer, Ruth; Flaherty, Keith T
Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations
2020-01-01 Remon J.; Passiglia F.; Ahn M.-J.; Barlesi F.; Forde P.M.; Garon E.B.; Gettinger S.; Goldberg S.B.; Herbst R.S.; Horn L.; Kubota K.; Lu S.; Mezquita L.; Paz-Ares L.; Popat S.; Schalper K.A.; Skoulidis F.; Reck M.; Adjei A.A.; Scagliotti G.V.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cd4 t cell–dependent rejection of beta-2 microglobulin null mismatch repair–deficient tumors | 2021 | Germano G.; Lu S.; Rospo G.; Lamba S.; Rousseau B.; Fanelli S.; Stenech D.; Le D.T.; Hays J.; Totaro M.G.; Amodio V.; Chila R.; Mondino A.; Diaz L.A.; Di Nicolantonio F.; Bardelli A. | |
| Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study | 2023 | Bai, Xue; Shaheen, Ahmed; Grieco, Charlotte; d'Arienzo, Paolo D; Mina, Florentia; Czapla, Juliane A; Lawless, Aleigha R; Bongiovanni, Eleonora; Santaniello, Umberto; Zappi, Helena; Dulak, Dominika; Williamson, Andrew; Lee, Rebecca; Gupta, Avinash; Li, Caili; Si, Lu; Ubaldi, Martina; Yamazaki, Naoya; Ogata, Dai; Johnson, Rebecca; Park, Benjamin C; Jung, Seungyeon; Madonna, Gabriele; Hochherz, Juliane; Umeda, Yoshiyasu; Nakamura, Yasuhiro; Gebhardt, Christoffer; Festino, Lucia; Capone, Mariaelena; Ascierto, Paolo Antonio; Johnson, Douglas B; Lo, Serigne N; Long, Georgina V; Menzies, Alexander M; Namikawa, Kenjiro; Mandala, Mario; Guo, Jun; Lorigan, Paul; Najjar, Yana G; Haydon, Andrew; Quaglino, Pietro; Boland, Genevieve M; Sullivan, Ryan J; Furness, Andrew J S; Plummer, Ruth; Flaherty, Keith T | |
| Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations | 2020 | Remon J.; Passiglia F.; Ahn M.-J.; Barlesi F.; Forde P.M.; Garon E.B.; Gettinger S.; Goldberg S.B.; Herbst R.S.; Horn L.; Kubota K.; Lu S.; Mezquita L.; Paz-Ares L.; Popat S.; Schalper K.A.; Skoulidis F.; Reck M.; Adjei A.A.; Scagliotti G.V. |